Media

Trianni, Inc. Signs Licensing Agreement with Straterx, Inc.

San Francisco, CA, USA, June 12, 2018 – Trianni, Inc. (“TRIANNI”) announced today that it has entered into a license […]

Continue reading

Trianni, Inc. and NovaRock Biotherapeutics, Ltd. Announce Licensing Agreement

San Francisco, CA, USA, March 28, 2018 – Trianni, Inc. (“TRIANNI”) and NovaRock Biotherapeutics, Ltd. (“NOVAROCK”) jointly announced today that […]

Continue reading

ENTHERA and TRIANNI Announce Licensing Agreement

San Francisco, CA, USA and Milano, Italy, March 22, 2018 – Trianni, Inc. (“TRIANNI”) and Enthera, S.r.l. (“ENTHERA”) jointly announced […]

Continue reading

TRIANNI Supports Immunology Program in Developing Regions

San Francisco, CA, USA., Feb 7, 2018 –Trianni, Inc. (“TRIANNI”) announced their support of the Education Committee of International Union […]

Continue reading

TRIANNI sponsors The Werner Müller Award for Excellence in Immunology

San Francisco, CA, USA. and Berlin, Germany, December 6, 2017 –Trianni, Inc. (“TRIANNI”) announced that it will sponsor the Werner […]

Continue reading

Trianni and Juno Therapeutics Sign Licensing Agreement for Use of Trianni Transgenic Mouse Platform

San Francisco, CA, USA, October 18, 2017– Trianni, Inc. (“TRIANNI”).  today announced that Juno Therapeutics (NASDAQ: JUNO) has entered into […]

Continue reading

TRIANNI Signs Agreement with Massachusetts General Hospital for Use of The Trianni Mouse™ in HIV Vaccine Research

San Francisco, CA, USA, June 1 2017 – Trianni, Inc. (“TRIANNI”) announced today that it has entered into an agreement […]

Continue reading

TRIANNI and Olympic Protein Technologies Sign License Agreement for The Trianni Mouse™

San Francisco, CA and Seattle, WA, USA., May 24, 2017 –Trianni, Inc. (“TRIANNI”) and Olympic Protein Technologies (“Olympic”) jointly announced […]

Continue reading

Immunomic Therapeutics and TRIANNI Sign License Agreement for The Trianni Mouse™

Rockville, MD and San Francisco, CA, USA, May 18, 2017–Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company, and […]

Continue reading

TRIANNI Signs Agreement with Magenta Therapeutics for Use of The Trianni Mouse

San Francisco, CA, USA., March 22, 2017 –Trianni, Inc. (“TRIANNI”) announced today that it has entered into a license agreement […]

Continue reading